(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KYMERA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KYMERA

ST13

US500000090981116

Class

42

Filing

90981116

Registration

7559572

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

64

Latest update

03/15/2026

Trademark type

Combined

Nice classes

42

Filing date

11/16/2020

Registration date

11/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/05/2024

Last transaction

03/15/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/31/2017

First use in commerce

10/31/2017

Drawing code

3

Owner type

03

Owner location

Watertown, MA, US

Examiner

DUFFIN, GRACE M

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of several geometric designs that form the basic elements of an animal face, with the wording "KYMERA" in capital stylized letters appearing to the right of the design and the "K" forming the base of the face.

Holders and representatives

Holders

Kymera Therapeutics, Inc.

Representatives

Lisa M. Tittemore Merchant & Gould P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of therapeutic drugs for the treatment of oncologyautoimmuneimmune-oncology and other related diseases; Research and development of pharmaceuticalsresearch and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products

Publications

History of USPTO decisions and trademark events.

64 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/13/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/13/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/13/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/06/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/05/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

09/12/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/17/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

07/17/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/10/2024

EX5G

SOU EXTENSION 5 GRANTED

07/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/26/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/26/2024

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

06/12/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/24/2024

IUAF

USE AMENDMENT FILED

04/26/2024

DRRR

DIVISIONAL REQUEST RECEIVED

04/26/2024

EXT5

SOU EXTENSION 5 FILED

04/26/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

04/26/2024

EISU

TEAS STATEMENT OF USE RECEIVED

04/26/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/26/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/19/2023

EX4G

SOU EXTENSION 4 GRANTED

10/17/2023

EXT4

SOU EXTENSION 4 FILED

10/17/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/17/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/20/2023

EX3G

SOU EXTENSION 3 GRANTED

04/18/2023

EXT3

SOU EXTENSION 3 FILED

04/18/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/18/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/21/2022

EX2G

SOU EXTENSION 2 GRANTED

10/19/2022

EXT2

SOU EXTENSION 2 FILED

10/19/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/19/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/27/2022

EX1G

SOU EXTENSION 1 GRANTED

04/25/2022

EXT1

SOU EXTENSION 1 FILED

04/25/2022

EEXT

SOU TEAS EXTENSION RECEIVED

04/25/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/26/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/31/2021

PUBO

PUBLISHED FOR OPPOSITION

08/31/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/11/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/27/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/02/2021

ALIE

ASSIGNED TO LIE

07/01/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/05/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/23/2021

GNRT

NON-FINAL ACTION E-MAILED

04/23/2021

CNRT

NON-FINAL ACTION WRITTEN

04/23/2021

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/23/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/23/2021

DOCK

ASSIGNED TO EXAMINER

04/22/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/15/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/14/2021

NWAP

NEW APPLICATION ENTERED

11/19/2020

Continuous trademark protection

Get notified about every new filing that threatens KYMERA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.